| Application no. and date | 08807092.5 (espacenet) (Federated) (European Patent Register), 20080916 | | Patent/reg. no. and date | DK/EP 2379066, 20140326 | | Publication date | 20111026 | | Priority no. and date | | | EP pub. no. and date |
EP 2379066 20111026 | | Effective date | | | Applicant/owner | Imunek Farma Ilaç Sanayi Ve Ticaret A.S., Pak is Merkezi Prof. Dr. Bülent Tarcan
Sok. No: 5/1
Gayrettepe
34349 Istanbul, TR | | Applicant ref. no. | RHEIN 08248EP | | Inventor | PISAK, Ibrahim Mustafa Iskender, Park Is Merkezi Prof. Dr. Bulent Tarcan
Sok. No: 5/1
Gayrettepe ISTANBUL 34349, TR,
SELAMOGLU, Mehmet Levent, Pak Is Merkezi Prof. Dr. Bulent Tarcan
Sok. No: 5/1
Gayrettepe ISTANBUL 34349, TR,
PAK, Nevhiz, Pak Is Merkezi Prof. Dr. Bulent Tarcan
Sok. No: 5/1
Gayrettepe ISTANBUL 34349, TR,
BINGOL, Semra, Pak Is Merkezi Prof. Dr. Bulent Tarcan
Sok. No: 5/1
Gayrettepe ISTANBUL 34349, TR | | Representative | RWS Group, RWS Compass House
Vanwall Business Park, Vanwall Road
Maidenhead, Berkshire
SL6 4UB, GB | | Opponent | | | IPC Class | A61K 31/485 (2006.01) , A61P 27/02 (2006.01) | | Title | ANVENDELSE AF OPIOIDANTAGONISTER TIL FREMSTILLING AF ET LÆGEMIDDEL TIL BEHANDLING AF RETINADEGENERATIONSSYGDOMME | | Int. application no. | IB2008002412 | | Int. publication no. | WO2010032073 | | Related patent (certificate) | | | Status | Bortfaldet | | Pædiatrisk forlængelse | - | | Udløbsdato for pædiatrisk forlængelse | - |
|
